Chimeric antigen receptor (CAR) T cell therapy has been an amazing advance for treating blood cancers like leukemia, lymphoma and multiple myeloma. Now, it is showing promise for solid tumors — from lung cancer to kidney cancer to bone cancer — as well. “We’re trying to adopt the same strategy that has worked in hematologic malignancies, where CAR T cell treatments have greatly increased survival,” says Samer Srour, MB ChB, assistant...
Read stories from survivors and caregivers, and get MD Anderson experts’ insights on cancer treatment, research breakthroughs, healthy living and more.